Holding in Company (9627A)

TIDMUDG

RNS Number : 9627A

United Drug PLC

05 April 2012

Standard Form TR-1 Voting rights attached to shares- Article 12(1) of directive 2004/109/EC Financial instruments - Article 11(3) of the Commission Directive 2007/14/EC

This notification is for filing purposes only in accordance with Regulation 22 of the Transparency (Directive 2004/109/EC) Regulations 2007.

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: United Drug Plc

   2.         Reason for the notification (please tick the appropriate box or boxes): 
   [u]     an acquisition or disposal of voting rights 

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

   [   ]     an event changing the breakdown of voting rights 
   3.         Full name of person(s) subject to the notification obligation: FMR LLC 
   4.         Full name of shareholder(s) (if different from 3.): see schedule 

5. Date of the transaction and date on which the threshold is crossed or reached: 04 April 2012

   6.         Date on which issuer notified; 05 April 2012 
   7.         Threshold(s) that is/are crossed or reached: 10% 
   8.         Notified details: 
 
 A) Voting rights attached to shares 
-------------------------------------------------------------------------------------------------- 
 Class/type         Situation previous        Resulting situation after the 
  of shares          to the Triggering         triggering transaction 
  (if possible       transaction 
  using the 
  ISIN CODE) 
-----------------  ------------------------  ----------------------------------------------------- 
                    Number       Number       Number       Number of voting      % of voting 
                     of Shares    of Voting    of shares    rights                rights 
                                  rights 
-----------------  -----------  -----------  -----------  --------------------  ------------------ 
                                              Indirect     Direct   Indirect     Direct   Indirect 
-----------------  -----------  -----------  -----------  -------  -----------  -------  --------- 
 IE0033024807       23,869,406   23,869,406   24,161,606            24,161,606            10.11 
-----------------  -----------  -----------  -----------  -------  -----------  -------  --------- 
 
 SUBTOTAL 
  A (based 
  on aggregate 
  voting rights)    23,869,406   23,869,406   24,161,606   24,161,606            10.11 
-----------------  -----------  -----------  -----------  --------------------  ------------------ 
 
 
 B) Financial Instruments 
--------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
--------------------------------------------------------------------------------------- 
 Type of       Expiration   Exercise/Conversion   Number of                 % of voting 
  financial     Date         Period/               voting rights             rights 
  instrument                 Date                  that may 
                                                   be acquired 
                                                   if the instrument 
                                                   is exercised/converted 
------------  -----------  --------------------  ------------------------  ------------ 
 
 
                            SUBTOTAL 
                             B (in relation 
                             to all expiration 
                             dates) 
                           --------------------  ------------------------  ------------ 
 
 
 Total (A+B)    number of        % of voting 
                 voting rights    rights 
-------------  ---------------  ------------ 
                24,161,606       10.11% 
-------------  ---------------  ------------ 
 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: See attached schedule

   10.       In case of proxy voting: Number of voting rights proxy holder will acquire is 292,200 
   11.       Additional information: None 

This announcement has been issued through the Companies Announcement Service of

The Irish Stock Exchange.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ISESSLFIIFESEFL